首页> 外文期刊>Chemical science >Biodegradable nanosyringes for intracellular amplification-based dual-diagnosis and gene therapy in single living cells
【24h】

Biodegradable nanosyringes for intracellular amplification-based dual-diagnosis and gene therapy in single living cells

机译:可生物降解的纳米注射器,用于单活细胞中基于细胞内扩增的双重诊断和基因治疗

获取原文
           

摘要

The efficient delivery of biomolecules into living cells as well as their easy biodegradation have been challenges for the application of intracellular amplification for sensitive multiple-diagnosis and gene therapy for cancer. Herein, new strategies of amplification-based dual-detection of cancer biomarkers (Let-7a miRNA and VEGF) and gene therapy for cancers are put forward. These are achieved through biodegradable nanosyringes (NSs), rigid and sharp in vitro but degradable in vivo , which are applied for the efficient loading, delivery and release of biomolecules (enzymes, nucleic acids, and even silencing RNA) into living cells. After penetrating cell membranes and escaping from endosomes through their rigid and sharp tips, NSs release biomolecules for fast and easy “one-step” rolling circle amplification (ring formation and amplification) in single living cells. Therefore, based on signals from two probes, FAM-Probe and Cy5-Probe, that selectively bind to amplification products, 100 aM of Let-7a and 100 fM of VEGF could be detected, which are much lower than reported values. Furthermore, siRNAs can also be delivered by NSs for gene therapy, and their therapeutic effect was evaluated by their in vivo antitumor efficacy in CCRF-CEM subcutaneous xenograft nude mice. Rigid in vitro and degradable in vivo , NSs show potential for achieving fast, sensitive and safe cancer diagnosis and efficient therapy.
机译:生物分子向活细胞中的有效传递及其容易的生物降解已经成为细胞内扩增在癌症敏感的多重诊断和基因治疗中的应用的挑战。在此,提出了基于扩增的双重检测癌症生物标记物(Let-7a miRNA和VEGF)和癌症基因治疗的新策略。这些是通过可生物降解的纳米注射器(NSs)实现的,它们在体外具有刚性和尖锐性,但在体内可降解,可用于将生物分子(酶,核酸,甚至沉默RNA)有效地加载,输送和释放到活细胞中。在穿透细胞膜并通过其坚硬而尖锐的尖端从核内体逸出后,NSs释放生物分子,从而在单个活细胞中快速,轻松地“一步”滚动圈扩增(环形成和扩增)。因此,根据来自选择性结合扩增产物的两种探针FAM-Probe和Cy5-Probe的信号,可以检测到100 aM的Let-7a和100 fM的VEGF,这远低于报道的值。此外,siRNA还可通过NSs进行基因治疗,并通过其在CCRF-CEM皮下异种移植裸鼠体内的抗肿瘤功效评估其治疗效果。 NS具有体外刚性和体内可降解性,显示出实现快速,敏感和安全的癌症诊断和有效治疗的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号